Vaccine dilemma for children at risk: Recently approved malaria vaccine versus ongoing COVID-19 vaccination campaign

Recently, the World Health Organization (WHO) approved RTS, S/AS01 (RTS, S) as the world's first malaria vaccine for partial malaria protection in young children at risk. While this immunization drive begins during the unprecedented pandemic of the SARS-CoV-2 Virus, the WHO has also approved 7...

Full description

Saved in:
Bibliographic Details
Published in:Annals of medicine and surgery 2022-07, Vol.79, p.104011-104011, Article 104011
Main Authors: Shah, Pritik A., Hasan, Mohammad Mehedi, Sahito, Abdul Moiz, Patel, Suyog Y., Ramproshad, Sarker, Mondal, Banani, Essar, Mohammad Yasir
Format: Article
Language:English
Subjects:
Malaria vaccine
Public health
RTS
S/AS01
SARS-CoV-2
Short Communication
Vaccination
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recently, the World Health Organization (WHO) approved RTS, S/AS01 (RTS, S) as the world's first malaria vaccine for partial malaria protection in young children at risk. While this immunization drive begins during the unprecedented pandemic of the SARS-CoV-2 Virus, the WHO has also approved 7 Vaccines in 2021 for the vaccination of children at risk. This article explores the quandary that would occur to the officials in charge of carrying out large vaccination campaigns against these two deadly infectious illnesses in several regions including the continent of Africa. The article also outlines the priorities for resolving this dilemma, offers evidence-based solutions, and provides a summary of recent significant events and their consequences. While providing the latest data, a discussion on the causation of the dilemma with clear recommendations for possible solutions has been explored as well.
ISSN:2049-0801
2049-0801
DOI:10.1016/j.amsu.2022.104011